Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
Want to see ADAPY full AI Analyst Report?
Technical Sentiment
Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics (ADAPY) Pivot Points
Classic
>-0.01
<0.01
0.01
0.01
0.02
0.02
0.03
Fibonacci
<0.01
<0.01
<0.01
0.01
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAPY) Moving Averages
MA5
0.02Sell
0.02Buy
MA10
0.02Buy
0.02Buy
MA20
0.02Buy
0.02Buy
MA50
0.02Buy
0.02Sell
MA100
0.03Sell
0.04Sell
MA200
0.07Sell
0.08Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.04, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.02, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.07, creating a Sell signal.
Adaptimmune Therapeutics (ADAPY) Technical Indicators
RSI (14)
51.70
Neutral
STOCH (9,6)
86.36
Sell
STOCHRSI (14)
86.36
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
44.10
Neutral
Williams %R
-13.64
Sell
CCI (14)
-1.00
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
96.03
Buy
ROC
100.00
Buy
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 51.70, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 44.10, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is -1.00, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Price Rate of Change (ROC) is 100.00, creating a Buy signal.
FAQ
Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Sell.
What is ADAPY’s RSI (14)?
ADAPY’s RSI (14) is 51.70, which suggests ADAPY is a Neutral.
What is ADAPY’s MACD?
ADAPY’s MACD is <0.01, which suggests ADAPY is a Sell.
What is ADAPY’s 5-day moving average?
ADAPY’s 5-day moving average is 0.02, which suggests ADAPY is a Sell.
What is ADAPY’s 20-day moving average?
ADAPY 20-day moving average is 0.02, which suggests ADAPY is a Buy.
What is ADAPY’s 50-day moving average?
ADAPY’s 50-day moving average is 0.02, which suggests ADAPY is a Buy.
What is ADAPY’s 200-day moving average?
ADAPY’s 200-day moving average is 0.07, which suggests ADAPY is a Sell.
What is ADAPY’s Williams % R (14)?
ADAPY’s Williams % R (14) is -13.64, which suggests ADAPY is a Sell.
What is ADAPY’s CCI (14)?
ADAPY’s CCI (14) is -1.00, which suggests ADAPY is a Neutral.